News
When it comes to DNA repair, it’s not one tool fits all
June 26, 2020
Our cells are constantly dividing, and as they do, the DNA molecule – our genetic code – sometimes gets broken. DNA has twin strands, and a break in both is considered especially dangerous. This kind of double-strand break can lead to genome rearrangements that are hallmarks of cancer cells, said James Daley, PhD, of the […]
Children more resilient against coronavirus, study finds
June 26, 2020
The majority of children with COVID-19 in 26 countries fared well clinically compared to adults during the first four months of the pandemic.
Study will compare treatment strategies for severe brain injury
June 12, 2020
A study of emergency care involving victims of severe brain trauma is to be performed in the San Antonio area.
Voelcker Fund awards $650,000 to cancer researchers on the rise
June 9, 2020
The Max and Minnie Tomerlin Voelcker Fund supports innovative cancer research projects conducted by rising star faculty members.
Stroke bleeds in the brain not decreasing, study finds
June 9, 2020
Brain bleeds called intracerebral hemorrhages remained stable in incidence among all age groups over the past 30 years, but they increased in people 75 and older, according to a new analysis of the Framingham Heart Study.
Researchers pinpoint a protein that may predict untreatable kidney cancer
June 4, 2020
A team of researchers confirmed the role of a certain protein in the development of high-grade kidney cancer. The researchers also showed that a higher level of the protein can be used as a marker to predict which tumors will develop treatment resistance and progress more rapidly.
Cancer drugs cause large cells that resist treatment; scientist aims to stop it
May 28, 2020
Fueled by genetic changes due to cancer therapy itself, rogue cells may become very large with twice or quadruple the number of chromosomes found in healthy cells. Dr. Daruka Mahadevan, of the Mays Cancer Center, seeks to find drugs that prevent or treat this problem.
Results published of remdesivir, COVID-19 trial
May 28, 2020
According to the study, the drug improved recovery time and decreased the number of deaths.
Second phase of clinical trial for promising COVID-19 drug begins
May 15, 2020
Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.
Don’t let COVID-19 keep you from getting stroke care
May 13, 2020
Even during the COVID-19 pandemic, patients should never hesitate to call an ambulance if they have signs of a stroke